Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIN1 | Q13526 | 8/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8077442 | 0.85 | PIN1 (0.37) | PIN1CYP1A2MAPK1CASP1CYP2C19 | |
| SCHEMBL8077446 | 0.85 | PARP1 (0.38) | PIN1CYP1A2MAPK1CASP1CYP2C19 | |
| SCHEMBL8919174 | 0.79 | PIN1 (0.53) | PIN1CYP1A2MAPK1CASP1CYP2C19 | |
| SCHEMBL3023228 | 0.79 | HSP90AA1 (0.39) | PIN1CYP1A2MAPK1CASP1CYP2C19 | |
| SCHEMBL27571567 | 0.77 | PIN1 (0.39) | PIN1HSP90AA1ESR2TDP1HCAR2 | |
| SCHEMBL3032708 | 0.76 | GPR35 (0.37) | PIN1CYP1A2MAPK1CASP1CYP2C19 | |
| SCHEMBL3023200 | 0.76 | ALDH1A1 (0.38) | PIN1CYP1A2MAPK1CASP1CYP2C19 | |
| SCHEMBL5433660 | 0.76 | PIN1 (0.38) | PIN1CYP1A2HSP90AA1ESR2TDP1 | |
| SCHEMBL28169947 | 0.74 | PIN1 (0.50) | PIN1CYP1A2MAPK1CASP1CYP2C19 | |
| SCHEMBL11475671 | 0.74 | PIN1 (0.50) | PIN1CYP1A2MAPK1CASP1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 440 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2026-02-12 | — | — | US | claimed |
| EP-4680369-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GE Vernova Technology GmbH (CH) | 2026-01-21 | — | — | EP | claimed |
| US-20250354659-A1 | SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION | NUOVO PIGNONE TECNOLOGIE – S R L (IT) | 2025-11-20 | — | — | US | claimed |
| EP-4572884-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | General Electric Technology GmbH (CH) | 2025-06-25 | — | — | EP | claimed |
| EP-4556112-A2 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | General Electric Technology GmbH (CH) | 2025-05-21 | — | — | EP | claimed |
| CN-119869460-A | Sorbent compositions, systems, and methods | 通用电气技术有限公司 | 2025-04-25 | — | — | CN | claimed |
| US-12263464-B2 | Method for in-situ synthesis of metal organic frameworks (MOFs), covalent organic frameworks (COFs) and zeolite imidazolate frameworks (ZIFs), and applications thereof | DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) | 2025-04-01 | — | — | US | claimed |
| CN-119656892-A | Hydrolyzed polyacrylonitrile-based zeolite imidazole framework membrane for ammonia separation and preparation method thereof | 福州大学 | 2025-03-21 | — | — | CN | claimed |
| CN-119056492-A | Filter membrane for removing DNA pollution in water and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2024-12-03 | — | — | CN | claimed |
| CN-118950092-A | MOF material with nuclease-like activity and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2024-11-15 | — | — | CN | claimed |
| CN-109055447-A | A kind of supercritical CO2The method that technique immobilized enzyme catalysis prepares 1,3 diglycerides | 江苏大学 | 2018-12-21 | — | — | CN | claimed |
| CN-103012501-B | Zn-Tb coordination polymer luminescent material based on like-amino acid ligand and preparation method thereof | UNIV LUOYANG NORMAL | 2015-03-11 | — | — | CN | claimed |
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-20140311507-A1 | Porous Catalytic Matrices for Elimination of Toxicants Found in Tobacco Combustion Products | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-10-23 | — | — | US | claimed |
| EP-2739169-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | Massachusetts Institute Of Technology (US) | 2014-06-11 | — | — | EP | claimed |
| CN-103012501-A | Zn-Tb coordination polymer luminescent material based on like-amino acid ligand and preparation method thereof | UNIV LUOYANG NORMAL | 2013-04-03 | — | — | CN | claimed |
| WO-2013019865-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-02-07 | — | — | WO | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| US-4662905-A | REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE | Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) | 1987-05-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | SRMS, TYRO3, SELE | PIN1 4360/4885CYP1A2 2002/4885MAPK1 3579/4885 |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | PIN1 44/4885CYP1A2 3261/4885MAPK1 2309/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | PIN1 1587/4885CYP1A2 1104/4885MAPK1 2694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.